67Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized

Joseph A Ioppolo1, Deanna Caldwell1, Omid Beiraghi1

  • 1Department of Chemistry and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada.

Abstract

Insights

New deferoxamine (DFO) derivatives show promise for imaging bacterial infections. These novel compounds are taken up by bacteria and can localize at infection sites, potentially improving diagnostic capabilities.

Area of Science:

  • Biomedical Imaging
  • Radiopharmaceutical Chemistry
  • Infectious Disease Diagnostics

Background:

  • Deferoxamine (DFO), a bacterial siderophore, can target iron-scavenging pathways.
  • Current imaging techniques for bacterial infections have limitations.
  • DFO's rapid in vivo clearance hinders its use for infection imaging.

Purpose of the Study:

  • Develop novel DFO derivatives for improved bacterial infection imaging.
  • Identify DFO derivatives with enhanced bacterial uptake and in vivo localization.
  • Optimize pharmacokinetic properties for effective infection detection.

Main Methods:

  • Synthesized a library of DFO derivatives via carbamate-forming reactions.
  • Labeled DFO and its derivatives with Gallium-67 (67Ga).
  • Assessed bacterial uptake and conducted biodistribution studies in infected mice.

Main Results:

  • 67Ga-labeled DFO derivatives achieved high radiochemical yield and purity.
  • Derivatives showed significant, albeit slower, uptake in *Staphylococcus aureus* compared to 67Ga-DFO.
  • An ethyl carbamate derivative demonstrated a high infected-to-non-infected ratio in vivo, despite non-specific organ uptake.

Conclusions:

  • Functionalized DFO-type siderophores retain bacterial uptake capabilities.
  • Novel 67Ga-labeled DFO derivatives are specifically taken up by *S. aureus*.
  • Siderophore-based radiopharmaceuticals show potential for imaging bacterial infections via iron-siderophore transport.